title: Emerging clinical spectrum of tumor necrosis factor receptor-associated periodic syndrome: comment on the articles by Hull et al and Dodé et al.
authors.forename: E
authors.initials: E
authors.lastname: Drewe
authors.forename: P C
authors.initials: PC
authors.lastname: Lanyon
authors.forename: R J
authors.initials: RJ
authors.lastname: Powell
mesh_terms: D000328:Adult; D015703:Antigens, CD / Q000235:genetics; D005190:Family; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000209:etiology / Q000235:genetics / Q000473:pathology*; D009154:Mutation; D010146:Pain / Q000209:etiology / Q000235:genetics / Q000473:pathology*; D010507:Periodicity; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics; D047888:Receptors, Tumor Necrosis Factor, Type I; D013577:Syndrome
chemical_list: D015703:Antigens, CD; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I